Cidara Thera (CDTX) Stock Price, Quote & News

Company Profile

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enab...

Industry: Biotechnology

Sector: Healthcare

Phone: (858) 752-6170

Website: www.cidara.com

Address:

6310 Nancy Ridge Drive, Suite 101, San Diego, United States

CaliEmpress Jun. 26 at 8:38 PM

$CDTX 282K Shares purchased at close! Biggest one block buy ever.

0 · Reply

Fordham619 Jun. 26 at 8:12 PM

$CDTX there is your answer

1 · Reply

percyoda Jun. 26 at 7:16 PM

$CDTX hey, where are y’all getting news for the offering? Was wondering if they’re posting updates on an investor relations page or something because I haven’t seen anything in a couple days Also, idk how legal this would be, but if I were an insider, I would be selling the hell out of this news and then drop a slightly lower than expected offering, after which I’d buy back stronger as they go into stage 3 trials They could all increase their positions significantly and gain favor with tutes But maybe I’m wrong which is why I need the news 🤔

1 · Reply

Diefreeandsell Jun. 26 at 5:48 PM

$CDTX Someone take away the punch bowl? Well someone got greedy and upped the offering to $350 mill, pretty damn good for co cash runway for when they finally get close to filing for PDUFA date in some future time if make it to PH3.

0 · Reply

CBVols Jun. 26 at 5:28 PM

$CDTX what happens if they can’t move these 8 million shares? We are a little more than halfway there and they wanted to close the offering today. Also have a genuine question- if shares aren’t moving at these prices, what makes you think this is going to go higher after the offering closes? I’m short here but I liquidated part of my position at a loss. I’m genuinely curious as to what everyone is thinking. I’ve been playing this game a while and it’s not you out I that’s making the money here, it’s the folks pulling the strings (and they are pulling them hard- and beautifully I might add)

3 · Reply

nv_me25 Jun. 26 at 5:02 PM

$CDTX wait will tomorrow!

1 · Reply

StockSurveyor69 Jun. 26 at 4:59 PM

$CDTX Back down to $30 we go. Time to pull out now

1 · Reply

Fordham619 Jun. 26 at 4:50 PM

$CDTX can this offering just close so we can get some certainty

0 · Reply

watchaddict Jun. 26 at 4:08 PM

$CDTX Fidelity Just borrowed all my cdtx shares. should i not loan them out?

1 · Reply

momo2021 Jun. 26 at 3:54 PM

$CDTX $COCP cc-42344 cocrystal is by far the most advanced H5N1 bird flu pill and seasonal on the planet the virology results are 1000x more powerful than tamiflu in phase 2a don't believe me do your own research if you liked the move in CDTX this will destroy that the stock is going to launch like no other v soon check please

0 · Reply

Cidara Therapeutics Advances CD388 To Phase 3, Reiterate Buy

Jun 24, 2025, 8:00 PM EDT - 1 day ago

Cidara Announces Pricing of Upsized Public Offering of Common Stock

Jun 23, 2025, 4:15 PM EDT - 3 days ago

Cidara Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 11:00 AM EDT - 3 days ago

Why Is Cidara Therapeutics Stock Trading Higher On Monday?

Jun 23, 2025, 7:00 AM EDT - 3 days ago

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

May 25, 2025, 9:26 PM EDT - 4 weeks ago

Cidara Therapeutics: All Stars Aligning In Favor Of CD388

May 15, 2025, 8:00 AM EDT - 6 weeks ago

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

May 13, 2025, 8:00 AM EDT - 6 weeks ago

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

May 10, 2025, 9:29 PM EDT - 6 weeks ago

Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:15 PM EDT - 7 weeks ago

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 5, 2025, 5:00 AM EDT - 7 weeks ago

Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate

May 1, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

Apr 30, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Apr 24, 2025, 8:00 AM EDT - 2 months ago

Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025

Apr 16, 2025, 8:00 AM EDT - 2 months ago

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

PHAT

Apr 1, 2025, 4:56 PM EDT - 3 months ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Apr 1, 2025, 4:05 PM EDT - 3 months ago

Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 19, 2025, 8:00 AM EDT - 3 months ago

Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response

Mar 18, 2025, 8:00 AM EDT - 3 months ago

Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025

Mar 17, 2025, 6:00 AM EDT - 3 months ago

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

Mar 6, 2025, 4:35 PM EST - 3 months ago

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 18, 2025, 4:15 PM EST - 4 months ago

Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer

Feb 11, 2025, 8:22 AM EST - 4 months ago

Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Jan 30, 2025, 4:05 PM EST - 5 months ago

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Nov 21, 2024, 3:12 PM EST - 7 months ago

Cidara: Potential To Change Flu Prophylaxis Landscape With CD388

Nov 21, 2024, 8:30 AM EST - 7 months ago

Cidara Therapeutics Announces $105 Million Private Placement

Nov 19, 2024, 8:00 AM EST - 7 months ago

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

Nov 7, 2024, 4:15 PM EST - 8 months ago

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 8:00 AM EDT - 8 months ago

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

Sep 25, 2024, 8:00 AM EDT - 9 months ago

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

Sep 23, 2024, 8:00 AM EDT - 9 months ago

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

Sep 19, 2024, 8:00 AM EDT - 10 months ago

Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

Sep 12, 2024, 4:05 PM EDT - 10 months ago

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

Sep 5, 2024, 8:00 AM EDT - 10 months ago

Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 19, 2024, 5:12 PM EDT - 11 months ago

Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer

Aug 13, 2024, 4:29 PM EDT - 11 months ago

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Jul 3, 2024, 1:05 PM EDT - 1 year ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 30, 2024, 8:00 AM EDT - 1 year ago

Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference

May 15, 2024, 4:20 PM EDT - 1 year ago

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

May 15, 2024, 4:01 PM EDT - 1 year ago

Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules

Apr 26, 2024, 6:01 PM EDT - 1 year ago

Cidara Therapeutics: Now Well-Funded To Advance Its Cloudbreak Platform

Apr 26, 2024, 8:00 AM EDT - 1 year ago

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

Apr 24, 2024, 7:19 PM EDT - 1 year ago

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Apr 24, 2024, 4:01 PM EDT - 1 year ago

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

Apr 22, 2024, 5:10 PM EDT - 1 year ago

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 22, 2024, 5:06 PM EDT - 1 year ago

Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice

Apr 22, 2024, 8:49 AM EDT - 1 year ago

Cidara Therapeutics Announces Reverse Stock Split

Apr 5, 2024, 3:00 PM EDT - 1 year ago

Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024

Mar 6, 2024, 8:00 AM EST - 1 year ago

Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024

CaliEmpress Jun. 26 at 8:38 PM

$CDTX 282K Shares purchased at close! Biggest one block buy ever.

0 · Reply

Fordham619 Jun. 26 at 8:12 PM

$CDTX there is your answer

1 · Reply

percyoda Jun. 26 at 7:16 PM

1 · Reply

Diefreeandsell Jun. 26 at 5:48 PM

0 · Reply

CBVols Jun. 26 at 5:28 PM

3 · Reply

nv_me25 Jun. 26 at 5:02 PM

$CDTX wait will tomorrow!

1 · Reply

StockSurveyor69 Jun. 26 at 4:59 PM

$CDTX Back down to $30 we go. Time to pull out now

1 · Reply

Fordham619 Jun. 26 at 4:50 PM

$CDTX can this offering just close so we can get some certainty

0 · Reply

watchaddict Jun. 26 at 4:08 PM

$CDTX Fidelity Just borrowed all my cdtx shares. should i not loan them out?

1 · Reply

momo2021 Jun. 26 at 3:54 PM

0 · Reply

momo2021 Jun. 26 at 3:37 PM

$COCP $CDTX wait is anyone doubting robert gave out $CYN 1 hour ago a free-be up over 100% for real parabolic cash?

0 · Reply

birdflustocks Jun. 26 at 3:33 PM

$CDTX @momo2021 It's a potential treatment option, and I hope it succeeds. But CD388 can act as preventative. Early treatment is a critical factor for all influenza antivirals and often treatment is delayed. https://www.nature.com/articles/s41467-025-60791-5 https://openres.ersjournals.com/content/7/1/00888-2020

1 · Reply

momo2021 Jun. 26 at 3:27 PM

$CYN just pulled out $190K in profits woo hoey let the rest ride $COCP $CDTX

1 · Reply

momo2021 Jun. 26 at 3:24 PM

$COCP $CDTX next momo $CYN real parabolic pass through $50

0 · Reply

Fordham619 Jun. 26 at 3:20 PM

$CDTX low volume today compared to the last week

0 · Reply

momo2021 Jun. 26 at 3:13 PM

$COCP $CDTX it was a free-be $CYN up $20+ already while we wait for cocrystal boom boom enjoy it well over $30 now on the next halt woo hoooooy

0 · Reply

Lstreak Jun. 26 at 3:08 PM

$CDTX Royal Bank Of Canada’s price target today $75.00.

0 · Reply

momo2021 Jun. 26 at 3:07 PM

$CDTX @birdflustocks if you want real virology results for an antiviral pill for all seasonal influenza and H5N1 bird flu all strains look at $COCP cc-42344 nothing comes close and its a pill that will be stockpiled https://www.cocrystalpharma.com/news/press-releases/detail/207/cocrystal-pharmas-investigational-drug-candidate

1 · Reply

momo2021 Jun. 26 at 2:58 PM

$CDTX $COCP you peeps should be thanking real with the real momo $CYN if you listened you would have already been up $10 in 30 minutes

0 · Reply

birdflustocks Jun. 26 at 2:56 PM

$CDTX @momo2021 There should be more results for newer genotypes, but this is still good if you consider that we can't know the pandemic influenza virus. Vaccination rates depend on policies and perceived benefits, up to 80% in the senior UK population. Trypanophobia, fear of needles, is a real but minor issue.

0 · Reply

kellyc09 Jun. 26 at 2:54 PM

$CDTX I believe in this stock and company. I love the way they handled the offering and infused cash. I hear the negative comments but I’m long and think it hits $60 this summer

0 · Reply

momo2021 Jun. 26 at 2:35 PM

$CDTX you want real parabolic be in this trade alrerady $CYN hahh

0 · Reply

Market Cap	587.70M
Revenue (ttm)	1.28M
Net Income (ttm)	-169.83M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-13,267.97%
Debt to Equity Ratio	0.00

Volume	1,850,733
Avg Vol	428,514
Day's Range	N/A - N/A
Shares Out	12.55M
Stochastic %K	80%
Beta	0.79
Analysts	Strong Sell
Price Target	$47.40